Our country is in the midst of an opioid epidemic. We are seeing staggering statistics of drug abuse, not to mention graphic images and videos of the effects drugs are having on families and their loved ones. While the FDA has taken a serious stance in the fight against drug abuse and has even come up with the FDA Opioids Action Plan, companies that work in the life sciences and healthcare industries also realize the seriousness of the problem.
How Artificial Intelligence Can Enhance the Clinical Data Review and Cleaning Process
This guide analyzes how artificial intelligence – including machine learning – can be used by pharmaceutical and medical device companies to improve the clinical data review and cleansing process.
From awareness campaigns to medication take-back days to ongoing safe medication disposal programs, we’re seeing a tremendous amount of activity and success with these initiatives. At the same time, the FDA is encouraging pharmaceutical companies to develop new, non-addictive drugs for patients in pain. That could be the ultimate lifesaver.
To learn about other trends that we can also expect to see in 2018, click here.